Since I have not posted in a while, I thought it would be good to give a current update of my stock portfolio. Here is my top 20 stocks in my Dividend Portfolio as of the end of 7/31/09 ranked by size of holdings.
1. Kinder Morgan Energy (KMP) USA
2. Barclays PLC ADR (BCS) UK
3. DCP Midstream Partners (DPM) USA
4. Johnson & Johnson (JNJ) USA
5. Procter & Gamble (PG) USA
6. HRPT Properties Trust (HRP) USA
7. American Capital (ACAS) USA
8. General Electric Company (GE) USA
9. Penn West Energy Trust (PWE) Canada
10. Diana Shipping Inc. (DSX) Greece
11. Exxon Mobil Corporation (XOM) USA
12. Banco Santander (STD) Spain
13. Deutsche Bank (DB) Germany
14. Cooper Tire & Rubber (CTB) USA
15. GlaxoSmithKline (GSK) UK
16. Aircastle Limited (AYR) USA
17. ONEOK, Inc. (OKE) USA
18. Duke Energy Corporation (DUK) USA
19. Newell Rubbermaid Inc. (NWL) USA
20. Pfizer Inc. (PFE) USA
Since I am a fan of the Tweedy Browne Funds, here is an update of the Tweedy, Browne Worldwide High Dividend Yield Value Fund as of the end of 6/30/09.
1. CNP Assurances France
2. Glaxosmithkline PLC UK
3. Philip Morris Int’l USA
4. Heineken NV Netherlands
5. Muenchener Rueckver Germany
6. Diageo PLC UK
7. Novartis AG Switzerland
8. 3M Co USA
9. Eni Spa Italy
10. Johnson & Johnson USA
11. Total SA France
12. Pearson PLC UK
13. Unilever NV Netherlands
14. Embotelladoras Arca Mexico
15. Coca Cola Co USA
16. Emerson Electric Co USA
17. AT&T Inc USA
18. Genuine Parts Co USA
19. Conocophillips USA
20. Telefonica SA Spain
Top 20 Stock Holdings
Posted by The Div Guy | Wednesday, August 05, 2009 | dividend stock, international, stock holdings | 7 comments »
Subscribe to:
Post Comments (Atom)
DSX isn't paying a dividend anymore.
gsk will RAISE dividend!
glaxo's preferred pandemic H1N1 (swine) flu vaccine is viewed as the most effective - globally, governments have signed contracts for at least 300 million orders so far
swine flu vaccine seems to be yielding low output compared to typical seasonal flu vaccines, but glaxo's proprietary adjuvant method raises the yield AND their vaccine's effectiveness especially against mutations of the swine flu strain
(people may demand to get the glaxo vaccine over others)
---
quote http://www.rep-am.com/News/429183.txt
Glaxo may reap 1.53 billion pounds ($2.53 billion) in swine flu-linked revenue in the next six months, according to Michael Leacock, a London-based analyst for RBS. That estimate doesn't take into account sales from a protective mask the company is developing. The U.K. drugmaker also makes Relenza, the second-biggest selling drug for people who have caught swine flu.
---
glaxo will raise its quarterly dividend to reflect this
glaxo - great fundamentals
good pipeline compared to peers
good dividend yield and it will be raised
Stiefel labs acquisition will be immediately accretive to earnings, with huge additional potential - a very timely buy
BMS (branded generics) acquisition will also be immediately accretive to earnings, a very nice purchase - this wasn't just a hedge purchase, it was an aggressive purchase to both take advantage of their competitors' drug patent expirations and weak drug pipelines
pharma hasn't participated much in this crazy rally and glaxo's fundamentals are great, and if there is any kind of flu panic, realistic or not, all the better!
Neither is ACAS. I plan to hold stocks that I think will recover and start paying a dividend in a year or two.
Manhattanbanker, I plan to hold GSK for the long term based on aging population, a good value play and a good drup pipeline.
In order to make small time investors understand the dynamics of stock markets and make them aware of India top stock picks, we have launched this stock picking portal. Fourstocks.com not only has BSE/NSE stock from which the players can pick stocks also stock recommendations either that of experts or members of stock picking community to help them choose India top stock picks.
India Top Stock Picks
http://www.fourstocks.com/
FourStocks.com allows users to compare their BSE/NSE equity picks with other members and street analysts. Its unique stock rating system provides a goldmine of investment ideas. The site also provides extensive financial information and gives a 3-dimensional view of companies and markets.
What does NHPC do? National Hydro Power Corporation has the biggest portfolio of hydro generation assets in India (13 projects, Installed capacity of 5175 MW). The organization has the experience, expertise and organizational setup to finance, build, own and operate large hydro generation plants. The company has plans to develop another 11 projects of 4600MW by 2014.